SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-21-000075
Filing Date
2021-03-25
Accepted
2021-03-25 16:16:35
Documents
5
Period of Report
2021-03-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm_march2021xuwpricing8-k.htm 8-K 25595
2 EX-1.1 evofem-underwritingagreeme.htm EX-1.1 343165
3 EX-5.1 evfm51opinion.htm EX-5.1 13940
4 GRAPHIC mintzfooter1.jpg GRAPHIC 20083
5 GRAPHIC mintzlogo1.jpg GRAPHIC 12460
  Complete submission text file 0001618835-21-000075.txt   418181
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 21772579
SIC: 2834 Pharmaceutical Preparations